
Neil A Halpern, MD
About Me
Mailing Address
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, Room M210
New York, NY 10021
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Medicine
Education
BA, Yeshiva University
MD, Mount Sinai School of Medicine
, The Mount Sinai Hospital
, University Health Center of Pittsburgh
Awards
2003
Physician's Recognition Award
American Medical Association
2001
Top Doctors New York Metro Area
Castle Connolly Medical, Ltd.
2000
Physician's Recognition Award
American Medical Association
1998
Certificate of Special Achievement
Department of Veterans Affairs Medical Center, Bronx, NY
1997
Physician's Recognition Award
American Medical Association
1993
Physician's Recognition Award
American Medical Association
1993
Certificate of Appreciation
Department of Veterans Affairs Medical Center, Bronx, NY
1992
Fellowship
American College of Critical Care Medicine (FCCM)
1991
Fellowship
American College of Angiology (FACA)
1990
Physician's Recognition Award
American Medical Association
1990
Certificate of Appreciation
Department of Veterans Affairs Medical Center, Bronx, NY
1990
Fellowship
American College of Chest Physicians (FCCP)
1990
Fellowship
American College of Physicians (FACP)
1988
Special Achievement Award
Department of Veterans Affairs Medical Center, Bronx, NY
1986
Who's Who in the East
Marquis Who's Who New Providence, NJ
1986
Who's Who in the East
Marquis Who's Who, New Providence, NJ
1977
Cum Laude
Yeshiva University
1977
Who's Who Among Students in American Colleges and Universities
Marquis Who's Who, New Providence, NJ
Research
A double blind, placebo controlled study of E5564, A Lipid A Antagonist administered by twice daily intravenous infusions in patients with severe sepsis
A multi-center randomized, double blind, parallel group-placebo controlled trial on efficacy and safety of activated Recombinant Factor VII (rFVIIa/NovoSeven ) in the treatment of bleeding in patients following hematopoietic stem cell transplantation
A Safety evaluation of Xigris (Drotecogin alfa activated) in Hematopoietic Stem Cell Transplant Patients with Severe Sepsis